Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
MB097 is an innovative oral precision Microbiome-based therapeutics developed by Microbiotica Limited for use in combination with immune checkpoint inhibitors (ICIs) to treat advanced melanoma. It consists of a defined consortium of nine bacterial strains, including four novel species and is currently being tested in the MELODY-1 international phase Ib clinical study
…